
Working with RDIF to ramp up Sputnik supplies: Dr. Reddy’s
The Hindu
Supply slowed down in recent weeks amid increase in COVID cases in Russia
Drugmaker Dr. Reddy’s Laboratories, which is the brand custodian of Russian vaccine Sputnik V in India, on Tuesday said it is working with the Russian Direct Investment Fund (RDIF) for ramping up the supplies. “We are also working with six contract manufacturing organisations in India for manufacturing readiness,” the company said in a statement forming part of its April-June quarter financial performance. During a virtual media interaction, CEO (API and Services) Deepak Sapra and CEO Branded Markets (India and EM) M.V.Ramana said the vaccine supplies that slowed down in recent weeks amid an increase in COVID-19 cases in Russia were expected to improve in August.More Related News













